Phase 2 Study of Tapentadol Prolonged Release in Cancer Pain Participants

NCT00805142 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

78

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain
Cancer

Interventions

DRUG: Tapentadol PR

Sponsor

Janssen Pharmaceutical K.K.

Collaborators

[object Object]